6 hrs ago | Myrtle Beach Online
The newest drugs may not always be the best
Last year pharmaceutical companies spent more than $4 billion urging patients like you to "ask your doctor" about their drugs.
Pulte Homes, Merck, Garmin are big movers
The following stocks were among those that moved substantially or traded heavily Wednesday on the New York Stock Exchange: NYSE: Pulte Homes Inc., up 32 cents at $9.55 Motorola, Alcoa, Procter & Gamble are big movers Motorola, Alcoa, Procter & Gamble are big movers The following stocks were among those that moved substantially or traded heavily ...
Pensions for top U.S. executive rose by an average of 19 percent last year, and more than 200 officers saw their retirement savings surge by as much as 50 percent, even as their companies stock prices fell, the Wall Street Journal reported on Monday.
Merck CEO Richard Clark says his company is looking to do more deals than ever, perhaps "even try to double" the current rate of 50 per year.
Biotech Stocks: Drug stocks gain; Alnylam slides
Drug stocks gained in early action Thursday, but shares of Alnylam Pharmaceuticals fell a day after it reported a widened third-quarter loss and said its search for research partners is taking longer than expected.
Merck, Now No. 2 Drugmaker, Set for Future Buys
The new Merck & Co . has become the world's second-biggest drugmaker overnight with a huge acquisition, but it still has a fat wallet and plans more wheeling and dealing.
Market Snapshot: Wall Street upbeat ahead of Fed decision
U.S. stocks traded higher Wednesday ahead of an afternoon decision from the Federal Reserve, which is expected to keep its benchmark interest rate at a record low.
Breast Cancer Vaccine Tests German Merck's Strategy for $1 Billion Payoff
Merck KGaA of Germany is gambling an unproven therapy that spurs the immune system to attack cancer cells will increase its share of a $48 billion oncology market.
Longer STEP Follow-up Suggests Adenovirus HIV Vaccine Did Not...
SUMMARY: Over a longer follow-up period, the apparent link between adenovirus type 5 immunity and increased risk of HIV infection in the STEP vaccine trial diminished, researchers reported at the AIDS Vaccine 2009 conference last week in Paris.
Schering-Plough reports data on hepatitis C drug
Schering-Plough Corp. said its experimental hepatitis C drug boceprevir helped eliminate the virus in about half of patients who did not respond to standard treatments.
FDA rejects Merck's drug application
U.S. regulators won't accept drugmaker Merck's application for a new combination cholesterol pill that includes rival Pfizer's Lipitor, the world's top-selling drug.
Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc.
These include several accepted drug-like characteristics and nanomolar potency. In its collaboration with Merck, Nuevolution is applying its proprietary Chemetics technology to identify novel small molecule leads against drug targets of interest to Merck.
Jack Mackenroth, from the hit reality television series "Project Runway," is visiting San Francisco for the United States Conference on AIDS and is bringing Living Positive By Design , his national HIV and AIDS education initiative, to the city.
FTC Order Restores Competition Lost Through Schering-Plougha s Acquisition of Merck
Merck & Co., Inc. must sell its interest in Merial Limited, an animal health joint venture with Sanofi-Aventis S.A., and Schering-Plough must sell its assets related to significant drugs for nausea and vomiting in humans, in order for Schering-Plough to complete its proposed $41.1 billion acquisition of Merck, the Federal Trade Commission announced ...
Freeport-McMoRan to replace Schering-Plough after merger with Merck, Priceline joins S&P 500
Standard & Poor's said Thursday it will add miner Freeport-McMoRan Copper & Gold Inc.
Competition Bureau Resolves Issues in Merger of Merck and Schering-Plough
The Competition Bureau announced today that it has reached an agreement with Merck & Co., Inc.
Swine Flu Doesn't Need to Save Novartis
Novartis has lots of moving parts, making it tricky to analyze, but it looks to me like the overall picture is pretty healthy.
Earnings Preview: Merck to report 3Q earnings
Merck & Co., a Dow component and the world's eighth-biggest drug maker by revenue, reports earnings for the third quarter on Thursday morning.
Merck says 3Q net income falls 28 percent
German drug and chemical maker Merck KGaA reported Monday that net income fell 28 percent to euro144 million in the third quarter as weak demand hurt revenue, but said its chemicals and liquid crystals divisions were recovering.
Merck says 3Q net income falls 28 percent
In this Oct. 22, 2008 file photo, Merck & Co. headquarters in Whitehouse Station, N.J. is shown.
Also on Topix